Results show that models trained on pooled metagenomes predict gut health status accurately and transfer to independent cohorts, providing a scalable, non-invasive framework and a set of candidate microbial biomarkers for further clinical evaluation.
Abstract
The gut microbiota is essential to maintain host physiology, and its disruption (dysbiosis) is associated with a wide range of diseases. Machine learning (ML) offers a powerful tool to model species-level microbiome profiles, but classifiers that reliably separate healthy from diseased individuals across independent cohorts are still lacking. In this study, we developed a ML classifiers trained on 7,452 publicly available stool metagenomes spanning 32 studies and 12 diseases, designed to distinguish healthy individuals (absence of a clinically diagnosed disease) from non-healthy individuals (presence of a clinically diagnosed disease) based on species-level gut microbiome profiles. We trained 16 supervised models combining four algorithms (RF, SVM-LIN, SVM-RBF, and LR-ElasticNet) combined with all feature sets and three feature-selection algorithms. Performance was assessed by F1 score and ROC–AUC on held-out test data and externally validated on 642 samples from six independent cohorts, including previously unseen diseases. On the test set, all models achieved F1 scores of 78–86% and ROC–AUC values of 89–95%. An SVM-RBF model using permutation-based feature selection performed best (F1 = 86.6%, ROC–AUC = 95.5%; healthy F1 = 86.6%, non-healthy F1 = 88.7%). Importantly, external validation confirmed the generalizability of the full-feature SVM-RBF model (overall F1 = 70.6%; ROC–AUC = 84.7%), including unseen disease types such as Clostridioides difficile infection (F1 = 90.3%) and type 2 diabetes (F1 = 77.4%). Feature-importance and multivariate analyses revealed both shared and disease-specific microbial signatures, suggesting that the model captures biologically meaningful patterns rather than cohort-specific artifacts. Disease-associated taxa included Klebsiella pneumoniae, Raoultella ornithinolytica, Sutterella wadsworthensis, Gemmiger formicilis, and Lactobacillus crispatus. In contrast, healthy status was consistently associated with commensal species such as Extibacter hylemonae and Ruthenibacterium lactatiformans. These results show that models trained on pooled metagenomes predict gut health status accurately and transfer to independent cohorts, providing a scalable, non-invasive framework and a set of candidate microbial biomarkers for further clinical evaluation.
Machine-learning models trained on gut microbiome data often achieve encouraging performance within individual cohorts, but their ability to generalize across independent populations remains uncertain. Although rheumatoid arthritis (RA) is associated with alterations in gut microbial composition, it remains unclear w...
Sabira Dabeer, H. Palitanawala· Scientific Reports· 0 citations
This single-center, cross-sectional case-control study aimed to characterize the gut microbiome profiles of patients with advanced colorectal cancer (CRC), identify candidate microbial features, and explore how well these features distinguished advanced CRC cases from healthy controls within the study dataset. Fecal sa...
Nan-Can Luo, Hui Yan, Nan Wang et al.· Archives of Microbiology· 0 citations
Collectively, co-abundance-defined microbial guilds capture coherent ecological and functional states of the gut microbiota, providing a transferable framework for linking gut microbiome organization to host physiology beyond conventional taxonomy-based classification.
Background: Inflammatory bowel disease (IBD) is characterised by severe intestinal microbial dysbiosis. Most machine learning diagnostic models built on the longitudinal HMP2 cohort suffer serious data leakage from random sample-level cross-validation splitting, which leads to artificially inflated AUC values. Addition...
Qiu-Peng Du, Lu Xing, Chen-Chen Zhu et al.· Genes· 0 citations
Obesity, type 2 diabetes mellitus (T2D), metabolic syndrome (MetS), and non-alcoholic fatty liver disease (NAFLD) are collectively the most rapidly growing group of non-communicable diseases, including global diabetes, which is expected to increase from 589 million adult cases in 2024 to 853 million in 2050. Current ri...
Neha Bokey, Sonal Mahajan· Genetics and Molecular Resea...· 0 citations
Microbiome-based classification of multiple neurological conditions is challenged by sparse features, class imbalance, and heterogeneity between studies. We propose Multi-Stream Adaptive Feature Integration (MASFI), which combines CLR-transformed genus-level features, taxonomy-derived features, and self-supervised taxo...
Miao-Miao Song, Ya-Ru Liu· Computers· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.